A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
|Articles|March 24, 2020
Contagion Live News Network: Coronavirus Updates for March 24, 2020
Author(s)Contagion® Editorial Staff
Stay up to date with the latest COVID-19 news from Contagion.
Advertisement
Welcome to the Contagion Live News Network. I’m Grant Gallagher and this is the COVID-19 update for Tuesday, March 24th, 2020.
The total number of cases in the US has now passed 50,000, with about 600 deaths.
Around the world, there are over 409,000 cases. There have been over 18,000 reported deaths, but also at least 106,000 recoveries.
Indian prime minister Modi has announced a 3-week lockdown for the nation. With a population of 1.3 billion people, India is the world’s second most populous country and the world’s fifth largest economy.
Meanwhile, President Trump has signaled that measures in the United States will be reassessed in about 2 weeks. According to the president, he’d like to see people heading back to work by Easter.
In clinical news, the American Academy of Otolaryngology put out a
In other clinical news, a new serological assay for SARS-CoV-2, the virus which causes COVID-19, was developed by a microbiology lab at the Icahn School of Medicine. I spoke with Dr. Florian Krammer about his laboratory’s work creating the assay,
Dr. Jason Pogue also spoke with Contagion recently, sharing his thoughts on the results of a randomized clinical trial evaluating
For other stories relevant to COVID-19, visit ContagionLive.com. To track the spread of infectious diseases in the United States and abroad, be sure to use the Contagion Outbreak Monitor.
For the Contagion Live News Network, I’m Grant Gallagher. Thanks for listening.
Advertisement
Related to this article
In the phase 3 LIBERTY study, the investigational monoclonal antibody, VYD2311, had significantly fewer adverse events than an mRNA COVID-19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the two were given together.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
The 18-year old resident of the state suffered from acute disseminated encephalomyelitis. Pennsylvania numbers are surging with some of the highest state totals of measles cases in the country.
In its second disease cluster this summer, city officials are cleaning building towers in the South Bronx amidst an ongoing investigation and are rolling out measures to prevent future Legionnaires' cases.
The death was reported in Jefferson County where the coroner released a statement announcing it was in an unvaccinated woman.
FDA approved updated 2026-2027 COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax's partners, all reformulated to target the XFG variant, giving clinicians several options ahead of the fall respiratory virus season.
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Advertisement
Advertisement
Trending on Contagion Live
1
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
2
Recent Guideline Updates in the Management of Urinary Tract Infections
3
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
4
Measles Update: October 2, 2026
5